Drug (abbreviations) | Brand name in the United States |
Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) | |
Abacavir (ABC) | Ziagen |
Emtricitabine (FTC) | Emtriva |
Lamivudine (3TC) | Epivir |
Stavudine (d4T) | Zerit¶ |
Tenofovir alafenamide (TAF) | Vemlidy |
Tenofovir disoproxil fumarate (TDF) | Viread |
Zidovudine (ZDV, AZT) | Retrovir |
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | |
Doravirine (DOR) | Pifeltro |
Efavirenz (EFV) | Sustiva |
Etravirine (ETR) | Intelence |
Nevirapine (NVP) | Viramune, Viramune XR¶ |
Rilpivirine (RPV) | Edurant |
Protease inhibitors (PIs) | |
Atazanavir (ATV) | Reyataz |
Atazanavir-cobicistat (ATV/COBI) | Evotaz |
Darunavir (DRV) | Prezista |
Darunavir-cobicistat (DRV/COBI) | Prezcobix |
Fosamprenavir (FPV) | Lexiva |
Lopinavir/ritonavir boosting (LPV/r) | Kaletra |
Nelfinavir (NFV) | Viracept |
Ritonavir (RTV) (used as a pharmacokinetic boosting agent) | Norvir |
Tipranavir (TPV) | Aptivus |
Fusion inhibitor | |
Enfuvirtide (T-20) | Fuzeon |
Integrase strand transfer inhibitors (INSTIs)* | |
Cabotegravir (CAB; oral formulation) | Vocabria |
Dolutegravir (DTG) | Tivicay, Tivicay PD |
Raltegravir (RAL) | Isentress, Isentress HD |
CCR5 antagonist | |
Maraviroc (MVC) | Selzentry |
Attachment inhibitor | |
Fostemsavir | Rukobia |
Post-attachment inhibitor | |
Ibalizumab (IBA) | Trogarzo |
Capsid inhibitor | |
Lenacapavir (LEN) | Sunlenca |
Fixed-dose oral combinations | |
Abacavir-lamivudine (ABC/3TC) | Epzicom |
Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) | Trizivir |
Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF) | Biktarvy |
Darunavir-cobicistat-emtricitabine-tenofovir alafenamide (DRV/COBI/FTC/TAF) | Symtuza |
Dolutegravir-abacavir-lamivudine (DTG/ABC/3TC) | Triumeq, Triumeq PD |
Dolutegravir-lamivudine (DTG/3TC) | Dovato |
Dolutegravir-rilpivirine (DTG/RPV) | Juluca |
Doravirine-lamivudine-tenofovir disoproxil fumarate (DOR/3TC/TDF) | Delstrigo |
Efavirenz-emtricitabine-tenofovir disoproxil fumarate (EFV/FTC/TDF) | Atripla¶ |
Efavirenz-lamivudine-tenofovir disoproxil fumarate (EFV/3TC/TDF) | Symfi, Symfi Lo |
Elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide (ECF/TAF or EVG/COBI/FTC/TAF) | Genvoya |
Elvitegravir-cobicistat-emtricitabine-tenofovir disoproxil fumarate (ECF/TDF or EVG/COBI/FTC/TDF) | Stribild |
Lamivudine-tenofovir disoproxil fumarate (3TC/TDF) | Cimduo |
Rilpivirine-emtricitabine-tenofovir alafenamide (RPV/FTC/TAF) | Odefsey |
Rilpivirine-emtricitabine-tenofovir disoproxil fumarate (RPV/FTC/TDF) | Complera |
Tenofovir alafenamide-emtricitabine (TAF/FTC) | Descovy |
Tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) | Truvada |
Zidovudine-lamivudine (ZDV/3TC) | Combivir |
Injectable combination | |
Cabotegravir-rilpivirine (CAB/RPV; extended-release injectable formulation) | Cabenuva |
* Some agents (eg, bictegravir, elvitegravir) are only available in fixed dose combinations and are listed in that category and not within their mechanistic class.
¶ Only available generically.Do you want to add Medilib to your home screen?